1-3 of 3
Abhay R. Satoskar
Close
Sort by
Journal Articles

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan, Jennifer A. Woyach, Samantha Jaglowski, Yiming Zhong, Joshua D. Hessler, Ta-Ming Liu, Betty Y. Chang, Karilyn M. Larkin, Matthew R. Stefanovski, Danielle L. Chappell, Frank W. Frissora, Lisa L. Smith, Kelly A. Smucker, Joseph M. Flynn, Jeffrey A. Jones, Leslie A. Andritsos, Kami Maddocks, Amy M. Lehman, Richard Furman, Jeff Sharman, Anjali Mishra, Michael A. Caligiuri, Abhay R. Satoskar, Joseph J. Buggy, Natarajan Muthusamy, Amy J. Johnson, John C. Byrd
Journal: Blood
Blood (2013) 122 (15): 2539–2549.
https://doi.org/10.1182/blood-2013-06-507947
Published: 2013
Includes: Supplemental data
Journal Articles

PI3Kgamma (PI3Kγ) is essential for efficient induction of CXCR3 on activated T cells

Brief Report
Joseph Barbi, Hannah E. Cummings, Bao Lu, Steve Oghumu, Thomas Rückle, Christian Rommel, William Lafuse, Caroline C. Whitacre, Abhay R. Satoskar
Journal: Blood
Blood (2008) 112 (8): 3048–3051.
https://doi.org/10.1182/blood-2008-02-135715
Published: 2008
Journal Articles

IFN-γ and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4 + but not CD8 + T cells

Joseph Barbi, Steve Oghumu, Claudio M. Lezama-Davila, Abhay R. Satoskar
Journal: Blood
Blood (2007) 110 (6): 2215–2216.
https://doi.org/10.1182/blood-2007-03-081307
Published: 2007